Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
Authors
Marcus Bantscheff,
Dirk EberhardYann Abraham,
Sonja Bastuck,
Markus Böesche,
Scott Hobson,
Toby Mathieson,
Jessica Perrin,
Manfred Raida,
Christina Rau,
Valérie Reader,
Gavain Sweetman,
Andreas Bauer,
Tewis Bouwmeester,
Carsten Hopf,
Ulrich Kruse,
Gitte Neubauer,
Nigel Ramsden,
Jens Rick,
Bernhard Küster +18 authors
,
Gerard Drewes Tip Tip